Oral Solid Dosage Pharmaceutical Formulation Market to Grow from US $493.2 Bn in 2017 to US $926.3 Bn by 2027 End
Instead of increasing pipeline productivity for biologics and patent cliff challenges, oral solid dosage forms hold substantial opportunity in extending product lifecycle and leveraging growth potential. Manufacturers are employing various life cycle management patent strategies which include obtaining patents on isomers, metabolites, prodrugs, and new drug formulations such as extended, controlled, or rapid release formulations.
View full press release